{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:35:56Z","timestamp":1789824956581,"version":"4.0.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T00:00:00Z","timestamp":1450224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T00:00:00Z","timestamp":1450224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Novel analytic tools are needed to elucidate the molecular basis of leukemia-relevant gene mutations in the post-genome era. We generated isogenic leukemia cell clones in which the FLT3 gene was disrupted in a single allele using TALENs. Isogenic clones with mono-allelic disrupted FLT3 were compared to an isogenic wild-type control clone and parental leukemia cells for transcriptional expression, downstream FLT3 signaling and proliferation capacity. The global gene expression profiles of mutant K562 clones and corresponding wild-type controls were compared using RNA-<jats:italic>seq<\/jats:italic>. The transcriptional levels and the ligand-dependent autophosphorylation of FLT3 were decreased in the mutant clones. TALENs-mediated FLT3 haplo-insufficiency impaired cell proliferation and colony formation <jats:italic>in vitro<\/jats:italic>. These inhibitory effects were maintained <jats:italic>in vivo<\/jats:italic>, improving the survival of NOD\/SCID mice transplanted with mutant K562 clones. Cluster analysis revealed that the gene expression pattern of isogenic clones was determined by the FLT3 mutant status rather than the deviation among individual isogenic clones. Differentially expressed genes between the mutant and wild-type clones revealed an activation of nonsense-mediated decay pathway in mutant K562 clones as well as an inhibited FLT3 signaling. Our data support that this genome-editing approach is a robust and generally applicable platform to explore the molecular bases of gene mutations.<\/jats:p>","DOI":"10.1038\/srep18454","type":"journal-article","created":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T10:19:01Z","timestamp":1450261141000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality"],"prefix":"10.1038","volume":"5","author":[{"given":"Jue","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongjuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqiu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,16]]},"reference":[{"key":"BFsrep18454_CR1","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/S0140-6736(08)60457-2","volume":"371","author":"CH Pui","year":"2008","unstructured":"Pui, C. H., Robison, L. L. & Look, A. T. Acute lymphoblastic leukaemia. Lancet 371, 1030\u20131043, doi: 10.1016\/S0140-6736(08)60457-2 (2008).","journal-title":"Lancet"},{"key":"BFsrep18454_CR2","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/leu.2011.317","volume":"26","author":"EH Estey","year":"2012","unstructured":"Estey, E. H. How to manage high-risk acute myeloid leukemia. Leukemia 26, 861\u2013869, doi: 10.1038\/leu.2011.317 (2012).","journal-title":"Leukemia"},{"key":"BFsrep18454_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1182\/asheducation-2011.1.30","volume":"2011","author":"JS Welch","year":"2011","unstructured":"Welch, J. S. & Link, D. C. Genomics of AML: clinical applications of next-generation sequencing. Hematology\/the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2011, 30\u201335, doi: 10.1182\/asheducation-2011.1.30 (2011).","journal-title":"Hematology\/the Education Program of the American Society of Hematology. American Society of Hematology. Education Program"},{"key":"BFsrep18454_CR4","doi-asserted-by":"publisher","first-page":"242","DOI":"10.5045\/br.2013.48.4.242","volume":"48","author":"A Mori","year":"2013","unstructured":"Mori, A. et al. Next generation sequencing: new tools in immunology and hematology. Blood research 48, 242\u2013249, doi: 10.5045\/br.2013.48.4.242 (2013).","journal-title":"Blood research"},{"key":"BFsrep18454_CR5","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.stem.2013.05.016","volume":"12","author":"FT Merkle","year":"2013","unstructured":"Merkle, F. T. & Eggan, K. Modeling human disease with pluripotent stem cells: from genome association to function. Cell stem cell 12, 656\u2013668, doi: 10.1016\/j.stem.2013.05.016 (2013).","journal-title":"Cell stem cell"},{"key":"BFsrep18454_CR6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1242\/dmm.002774","volume":"3","author":"C Vicente-Duenas","year":"2010","unstructured":"Vicente-Duenas, C., Cobaleda, C., Perez-Losada, J. & Sanchez-Garcia, I. The evolution of cancer modeling: the shadow of stem cells. Disease models & mechanisms 3, 149\u2013155, doi: 10.1242\/dmm.002774 (2010).","journal-title":"Disease models & mechanisms"},{"key":"BFsrep18454_CR7","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1534\/genetics.110.120717","volume":"186","author":"M Christian","year":"2010","unstructured":"Christian, M. et al. Targeting DNA double-strand breaks with TAL effector nucleases. Genetics 186, 757\u2013761, doi: 10.1534\/genetics.110.120717 (2010).","journal-title":"Genetics"},{"key":"BFsrep18454_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nbt.1755","volume":"29","author":"JC Miller","year":"2011","unstructured":"Miller, J. C. et al. A TALE nuclease architecture for efficient genome editing. Nature biotechnology 29, 143\u2013148, doi: 10.1038\/nbt.1755 (2011).","journal-title":"Nature biotechnology"},{"key":"BFsrep18454_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrm3486","volume":"14","author":"JK Joung","year":"2013","unstructured":"Joung, J. K. & Sander, J. D. TALENs: a widely applicable technology for targeted genome editing. Nature reviews. Molecular cell biology 14, 49\u201355, doi: 10.1038\/nrm3486 (2013).","journal-title":"Nature reviews. Molecular cell biology"},{"key":"BFsrep18454_CR10","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nbt.2951","volume":"32","author":"D Heckl","year":"2014","unstructured":"Heckl, D. et al. Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing. Nature biotechnology 32, 941\u2013946, doi: 10.1038\/nbt.2951 (2014).","journal-title":"Nature biotechnology"},{"key":"BFsrep18454_CR11","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1093\/nar\/gkr218","volume":"39","author":"T Cermak","year":"2011","unstructured":"Cermak, T. et al. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic acids research 39, e82, doi: 10.1093\/nar\/gkr218 (2011).","journal-title":"Nucleic acids research"},{"key":"BFsrep18454_CR12","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1182\/blood-2003-06-1845","volume":"103","author":"K Ozeki","year":"2004","unstructured":"Ozeki, K. et al. Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia. Blood 103, 1901\u20131908, doi: 10.1182\/blood-2003-06-1845 (2004).","journal-title":"Blood"},{"key":"BFsrep18454_CR13","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1182\/blood-2003-01-0162","volume":"102","author":"M Libura","year":"2003","unstructured":"Libura, M. et al. FLT3 and MLL intragenic abnormalities in AML reflect a common category of genotoxic stress. Blood 102, 2198\u20132204, doi: 10.1182\/blood-2003-01-0162 (2003).","journal-title":"Blood"},{"key":"BFsrep18454_CR14","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.leukres.2005.07.015","volume":"30","author":"M Inomata","year":"2006","unstructured":"Inomata, M. et al. Inverse correlation between Flt3 and PU.1 expression in acute myeloblastic leukemias. Leukemia research 30, 659\u2013664, doi: 10.1016\/j.leukres.2005.07.015 (2006).","journal-title":"Leukemia research"},{"key":"BFsrep18454_CR15","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1158\/1078-0432.CCR-10-1613","volume":"18","author":"D Cilloni","year":"2012","unstructured":"Cilloni, D. & Saglio, G. Molecular pathways: BCR-ABL. Clinical cancer research : an official journal of the American Association for Cancer Research 18, 930\u2013937, doi: 10.1158\/1078-0432.CCR-10-1613 (2012).","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"key":"BFsrep18454_CR16","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/nrc1169","volume":"3","author":"DL Stirewalt","year":"2003","unstructured":"Stirewalt, D. L. & Radich, J. P. The role of FLT3 in haematopoietic malignancies. Nature reviews. Cancer 3, 650\u2013665, doi: 10.1038\/nrc1169 (2003).","journal-title":"Nature reviews. Cancer"},{"key":"BFsrep18454_CR17","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.cell.2011.06.019","volume":"146","author":"F Soldner","year":"2011","unstructured":"Soldner, F. et al. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell 146, 318\u2013331, doi: 10.1016\/j.cell.2011.06.019 (2011).","journal-title":"Cell"},{"key":"BFsrep18454_CR18","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/jnci\/djm328","volume":"100","author":"W Zhang","year":"2008","unstructured":"Zhang, W. et al. Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia. Journal of the National Cancer Institute 100, 184\u2013198, doi: 10.1093\/jnci\/djm328 (2008).","journal-title":"Journal of the National Cancer Institute"},{"key":"BFsrep18454_CR19","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1182\/blood-2009-05-222034","volume":"114","author":"PP Zarrinkar","year":"2009","unstructured":"Zarrinkar, P. P. et al. AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML). Blood 114, 2984\u20132992, doi: 10.1182\/blood-2009-05-222034 (2009).","journal-title":"Blood"},{"key":"BFsrep18454_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev.biochem.76.050106.093909","volume":"76","author":"YF Chang","year":"2007","unstructured":"Chang, Y. F., Imam, J. S. & Wilkinson, M. F. The nonsense-mediated decay RNA surveillance pathway. Annual review of biochemistry 76, 51\u201374, doi: 10.1146\/annurev.biochem.76.050106.093909 (2007).","journal-title":"Annual review of biochemistry"},{"key":"BFsrep18454_CR21","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.leukres.2009.11.008","volume":"34","author":"KI Kim","year":"2010","unstructured":"Kim, K. I. et al. Molecular characterization and prognostic significance of FLT3 in CML progression. Leukemia research 34, 995\u20131001, doi: 10.1016\/j.leukres.2009.11.008 (2010).","journal-title":"Leukemia research"},{"key":"BFsrep18454_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1532\/IJH97.05090","volume":"82","author":"C Choudhary","year":"2005","unstructured":"Choudhary, C., Muller-Tidow, C., Berdel, W. E. & Serve, H. Signal transduction of oncogenic Flt3. International journal of hematology 82, 93\u201399, doi: 10.1532\/IJH97.05090 (2005).","journal-title":"International journal of hematology"},{"key":"BFsrep18454_CR23","doi-asserted-by":"crossref","unstructured":"Small, D. FLT3 mutations: biology and treatment. Hematology\/the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 178\u2013184, doi: 10.1182\/asheducation-2006.1.178 (2006).","DOI":"10.1182\/asheducation-2006.1.178"},{"key":"BFsrep18454_CR24","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/j.1365-2141.2007.06696.x","volume":"138","author":"KT Kim","year":"2007","unstructured":"Kim, K. T. et al. Constitutive Fms-like tyrosine kinase 3 activation results in specific changes in gene expression in myeloid leukaemic cells. British journal of haematology 138, 603\u2013615, doi: 10.1111\/j.1365-2141.2007.06696.x (2007).","journal-title":"British journal of haematology"},{"key":"BFsrep18454_CR25","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1242\/dmm.010652","volume":"6","author":"MG Toscano","year":"2013","unstructured":"Toscano, M. G. et al. Use of zinc-finger nucleases to knock out the WAS gene in K562 cells: a human cellular model for Wiskott-Aldrich syndrome. Disease models & mechanisms 6, 544\u2013554, doi: 10.1242\/dmm.010652 (2013).","journal-title":"Disease models & mechanisms"},{"key":"BFsrep18454_CR26","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1242\/dmm.012054","volume":"6","author":"K Musunuru","year":"2013","unstructured":"Musunuru, K. Genome editing of human pluripotent stem cells to generate human cellular disease models. Disease models & mechanisms 6, 896\u2013904, doi: 10.1242\/dmm.012054 (2013).","journal-title":"Disease models & mechanisms"},{"key":"BFsrep18454_CR27","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.stem.2012.11.011","volume":"12","author":"Q Ding","year":"2013","unstructured":"Ding, Q. et al. A TALEN genome-editing system for generating human stem cell-based disease models. Cell stem cell 12, 238\u2013251, doi: 10.1016\/j.stem.2012.11.011 (2013).","journal-title":"Cell stem cell"},{"key":"BFsrep18454_CR28","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1182\/blood-2004-07-2758","volume":"105","author":"DK Walters","year":"2005","unstructured":"Walters, D. K., Stoffregen, E. P., Heinrich, M. C., Deininger, M. W. & Druker, B. J. RNAi-induced down-regulation of FLT3 expression in AML cell lines increases sensitivity to MLN518. Blood 105, 2952\u20132954, doi: 10.1182\/blood-2004-07-2758 (2005).","journal-title":"Blood"},{"key":"BFsrep18454_CR29","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1177\/147323001103900508","volume":"39","author":"CM Wang","year":"2011","unstructured":"Wang, C. M. et al. Effect of small interfering RNA targeting wild-type FLT3 in acute myeloid leukaemia cells in vitro and in vivo. The Journal of international medical research 39, 1661\u20131674 (2011).","journal-title":"The Journal of international medical research"},{"key":"BFsrep18454_CR30","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S1535-6108(03)00003-5","volume":"3","author":"SA Armstrong","year":"2003","unstructured":"Armstrong, S. A. et al. Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification. Cancer cell 3, 173\u2013183 (2003).","journal-title":"Cancer cell"},{"key":"BFsrep18454_CR31","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1182\/blood-2010-06-289207","volume":"118","author":"S Kharazi","year":"2011","unstructured":"Kharazi, S. et al. Impact of gene dosage, loss of wild-type allele and FLT3 ligand on Flt3-ITD-induced myeloproliferation. Blood 118, 3613\u20133621, doi: 10.1182\/blood-2010-06-289207 (2011).","journal-title":"Blood"},{"key":"BFsrep18454_CR32","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/1074-7613(95)90167-1","volume":"3","author":"K Mackarehtschian","year":"1995","unstructured":"Mackarehtschian, K. et al. Targeted disruption of the flk2\/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 3, 147\u2013161 (1995).","journal-title":"Immunity"},{"key":"BFsrep18454_CR33","doi-asserted-by":"publisher","first-page":"4490","DOI":"10.1182\/blood-2007-09-115055","volume":"111","author":"L Bullinger","year":"2008","unstructured":"Bullinger, L. et al. An FLT3 gene-expression signature predicts clinical outcome in normal karyotype AML. Blood 111, 4490\u20134495, doi: 10.1182\/blood-2007-09-115055 (2008).","journal-title":"Blood"},{"key":"BFsrep18454_CR34","doi-asserted-by":"publisher","first-page":"R210","DOI":"10.1093\/hmg\/ddq376","volume":"19","author":"B Tycko","year":"2010","unstructured":"Tycko, B. & Allele-specific D. N. A. methylation: beyond imprinting. Human molecular genetics 19, R210\u2013220, doi: 10.1093\/hmg\/ddq376 (2010).","journal-title":"Human molecular genetics"},{"key":"BFsrep18454_CR35","doi-asserted-by":"publisher","first-page":"38427","DOI":"10.1074\/jbc.C112.408864","volume":"287","author":"J Valton","year":"2012","unstructured":"Valton, J. et al. Overcoming transcription activator-like effector (TALE) DNA binding domain sensitivity to cytosine methylation. The Journal of biological chemistry 287, 38427\u201338432, doi: 10.1074\/jbc.C112.408864 (2012).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep18454_CR36","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1038\/cr.2012.127","volume":"22","author":"D Deng","year":"2012","unstructured":"Deng, D. et al. Recognition of methylated DNA by TAL effectors. Cell research 22, 1502\u20131504, doi: 10.1038\/cr.2012.127 (2012).","journal-title":"Cell research"},{"key":"BFsrep18454_CR37","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nbt.2517","volume":"31","author":"Y Kim","year":"2013","unstructured":"Kim, Y. et al. A library of TAL effector nucleases spanning the human genome. Nature biotechnology 31, 251\u2013258, doi: 10.1038\/nbt.2517 (2013).","journal-title":"Nature biotechnology"},{"key":"BFsrep18454_CR38","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1101\/gr.147314.112","volume":"23","author":"M Piganeau","year":"2013","unstructured":"Piganeau, M. et al. Cancer translocations in human cells induced by zinc finger and TALE nucleases. Genome research 23, 1182\u20131193, doi: 10.1101\/gr.147314.112 (2013).","journal-title":"Genome research"},{"key":"BFsrep18454_CR39","doi-asserted-by":"publisher","first-page":"W117","DOI":"10.1093\/nar\/gks608","volume":"40","author":"EL Doyle","year":"2012","unstructured":"Doyle, E. L. et al. TAL Effector-Nucleotide Targeter (TALE-NT) 2.0: tools for TAL effector design and target prediction. Nucleic acids research 40, W117\u2013122, doi: 10.1093\/nar\/gks608 (2012).","journal-title":"Nucleic acids research"},{"key":"BFsrep18454_CR40","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nbt.1939","volume":"29","author":"P Huang","year":"2011","unstructured":"Huang, P. et al. Heritable gene targeting in zebrafish using customized TALENs. Nature biotechnology 29, 699\u2013700, doi: 10.1038\/nbt.1939 (2011).","journal-title":"Nature biotechnology"},{"key":"BFsrep18454_CR41","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/nbt.2170","volume":"30","author":"D Reyon","year":"2012","unstructured":"Reyon, D. et al. FLASH assembly of TALENs for high-throughput genome editing. Nature biotechnology 30, 460\u2013465, doi: 10.1038\/nbt.2170 (2012).","journal-title":"Nature biotechnology"},{"key":"BFsrep18454_CR42","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/978-1-60761-753-2_15","volume":"649","author":"DY Guschin","year":"2010","unstructured":"Guschin, D. Y. et al. A rapid and general assay for monitoring endogenous gene modification. Methods in molecular biology 649, 247\u2013256, doi: 10.1007\/978-1-60761-753-2_15 (2010).","journal-title":"Methods in molecular biology"},{"key":"BFsrep18454_CR43","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nmeth.1456","volume":"7","author":"Y Doyon","year":"2010","unstructured":"Doyon, Y. et al. Transient cold shock enhances zinc-finger nuclease-mediated gene disruption. Nature methods 7, 459\u2013460, doi: 10.1038\/nmeth.1456 (2010).","journal-title":"Nature methods"},{"key":"BFsrep18454_CR44","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1182\/blood-2004-03-0940","volume":"105","author":"J Schwable","year":"2005","unstructured":"Schwable, J. et al. RGS2 is an important target gene of Flt3-ITD mutations in AML and functions in myeloid differentiation and leukemic transformation. Blood 105, 2107\u20132114, doi: 10.1182\/blood-2004-03-0940 (2005).","journal-title":"Blood"},{"key":"BFsrep18454_CR45","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1182\/blood-2004-07-2942","volume":"106","author":"C Choudhary","year":"2005","unstructured":"Choudhary, C. et al. AML-associated Flt3 kinase domain mutations show signal transduction differences compared with Flt3 ITD mutations. Blood 106, 265\u2013273, doi: 10.1182\/blood-2004-07-2942 (2005).","journal-title":"Blood"},{"key":"BFsrep18454_CR46","doi-asserted-by":"publisher","first-page":"e107050","DOI":"10.1371\/journal.pone.0107050","volume":"9","author":"H Bai","year":"2014","unstructured":"Bai, H. et al. Identification of genes related to beak deformity of chickens using digital gene expression profiling. PloS one 9, e107050, doi: 10.1371\/journal.pone.0107050 (2014).","journal-title":"PloS one"},{"key":"BFsrep18454_CR47","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/bioinformatics\/bth078","volume":"20","author":"MJ de Hoon","year":"2004","unstructured":"de Hoon, M. J., Imoto, S., Nolan, J. & Miyano, S. Open source clustering software. Bioinformatics 20, 1453\u20131454, doi: 10.1093\/bioinformatics\/bth078 (2004).","journal-title":"Bioinformatics"},{"key":"BFsrep18454_CR48","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1093\/bioinformatics\/bth349","volume":"20","author":"AJ Saldanha","year":"2004","unstructured":"Saldanha, A. J. Java Treeview\u2014extensible visualization of microarray data. Bioinformatics 20, 3246\u20133248, doi: 10.1093\/bioinformatics\/bth349 (2004).","journal-title":"Bioinformatics"},{"key":"BFsrep18454_CR49","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1101\/gr.124321.111","volume":"21","author":"S Tarazona","year":"2011","unstructured":"Tarazona, S., Garcia-Alcalde, F., Dopazo, J., Ferrer, A. & Conesa, A. Differential expression in RNA-seq: a matter of depth. Genome research 21, 2213\u20132223, doi: 10.1101\/gr.124321.111 (2011).","journal-title":"Genome research"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep18454.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep18454","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep18454.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T20:14:03Z","timestamp":1672949643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep18454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,16]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,22]]}},"alternative-id":["BFsrep18454"],"URL":"https:\/\/doi.org\/10.1038\/srep18454","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,16]]},"assertion":[{"value":"19 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18454"}}